FDMT 4D Molecular Therapeutics: Year-over-year net earnings per share growth for the last 12 months

4D Molecular Corp (FDMT) - corporate logo

Evaluating quarterly EPS growth allows for an analysis of earnings per share dynamics, while -6.70 shows the value of this parameter. 4D Molecular Therapeutics (FDMT) operates in an environment of fierce competition for capital against big pharma behemoths. The success of 4D Molecular Therapeutics (FDMT) relies on the scientific potential of its leadership and innovative AAV platforms, however, any failures in ophthalmology drug trials or a shortage of in-house capacity create serious risks.

4D Molecular Therapeutics, Inc. (FDMT) - Year-over-year earnings per share growth for the last twelve months from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for 4dmoleculartherapeutics.com (FDMT)

- stock quotes and analyst forecast:
Basic company analysis:FDMT (4D Molecular Corp)
Flagship merchandise of 4D Molecular Therapeutics

The scale of 4D Molecular Therapeutics (FDMT) developments in gene therapy requires aligning operating expenses with the growth rates of quarterly net earnings per share. This indicator filters out market noise, focusing attention on the fundamental stability of the business. The calculation is based on the percentage change in EPS for the current quarter compared to the same period last year. For a biotech company, this reflects the investment efficiency in energy-intensive biomaterial storage and ESG protocols. Investors utilize this trend to determine the true price floor.

Main competitors

TEM: Quarterly EPS earnings growth|Qiagen Corp - Year-over-year earnings per one share growth for the last 12 months|IONS (Ionis Pharmaceuticals) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months RGEN (Repligen)|Quarterly EPS earnings growth RNA|CRSP (CRISPR Therapeutics) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth WGS (GeneDx Holdings Corp.)|RARE: Year-over-year earnings per share growth for the last 12 months|BEAM - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months sarepta.com|TWST: Quarterly EPS earnings growth|TXG - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Intellia|Earnings per share growth in annualized terms for the last twelve months Stoke Therapeutics STOK|Quarterly EPS earnings growth BLFS|Wave Life Sciences - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth MAZE (Maze Therapeutics, Inc.)|Quarterly EPS earnings growth Sionna Pharma SION|Prime Medicine Bio - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months TSHA (Taysha)|QURE: Quarterly EPS earnings growth|MGTX - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months RGNX|SLDB: Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months ocugen.com (OCGN)|Year-over-year net earnings per share change for the last twelve months PacBio Corp|Year-over-year earnings per share growth for the last twelve months Benitec Biopharma BNTC|DSGN: Year-over-year earnings per share growth for the last 12 months|RCKT - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Lexeo Therapeutics, Inc.|Korro Bio (KRRO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months EDIT|SLN (Silence Therapeutics plc) - Quarterly EPS earnings growth|proqr.com (PRQR) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months CDXS (Codexis Bio)|SGMO - Earnings per share growth in annualized terms for the last twelve months|Nautilus Biotechnology, Inc. - Year-over-year net earnings per share growth for the last 12 months|Net earnings per share growth for the trailing year Metagenomi, Inc|Precision BioSciences - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year generationbio.com (GBIO)|Boundless Bio Inc (BOLD) - Year-over-year earnings per share growth for the last twelve months|Exicure Inc. - Year-over-year earnings per one share growth for the last 12 months|IMNN (imunon.com) - Quarterly EPS earnings growth|Phio Pharmaceuticals - Year-over-year net earnings per share trend for the last twelve months|Year-over-year earnings per share growth for the last twelve months Mustang Bio Corp (MBIO)|Quarterly EPS earnings growth TransCode (RNAZ)|Quarterly EPS earnings growth BNGO (bionanogenomics.com)|APDN (Applied DNA Sciences Inc) - Year-over-year net earnings per share trend for the last twelve months|BLUE - Year-over-year earnings per share growth for the last twelve months|ImmunoPrecise Antibodies Ltd. (IPA) - Year-over-year net earnings per share growth for the last 12 months|OMGA (Omega) - Year-over-year net earnings per share growth for the last 12 months|singulargenomics.com (OMIC) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months RGLS|Syros (SYRS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months telesisbio.com (TBIO)|TCON - Earnings per share growth in annualized terms for the last twelve months|Quarterly EPS earnings growth UBX (Unity Biotechnology Inc.)